アンジェスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/08/10 | 71,500 | 73,200 | 70,000 | 71,500 | +1,500 | +2.1% | 148 |
2011/08/09 | 64,200 | 71,800 | 61,300 | 70,000 | +2,800 | +4.2% | 450 |
2011/08/08 | 67,300 | 75,500 | 67,000 | 67,200 | -1,100 | -1.6% | 193 |
2011/08/05 | 68,800 | 68,800 | 66,000 | 68,300 | -2,200 | -3.1% | 239 |
2011/08/04 | 70,900 | 71,800 | 70,400 | 70,500 | -1,000 | -1.4% | 102 |
2011/08/03 | 71,500 | 71,500 | 70,000 | 71,500 | -800 | -1.1% | 151 |
2011/08/02 | 74,400 | 74,400 | 71,600 | 72,300 | -1,200 | -1.6% | 126 |
2011/08/01 | 73,100 | 75,000 | 73,100 | 73,500 | -500 | -0.7% | 85 |
2011/07/29 | 75,200 | 76,000 | 73,000 | 74,000 | -2,800 | -3.6% | 224 |
2011/07/28 | 77,000 | 77,300 | 76,500 | 76,800 | -300 | -0.4% | 97 |
2011/07/27 | 77,700 | 77,700 | 77,000 | 77,100 | -600 | -0.8% | 88 |
2011/07/26 | 77,800 | 78,000 | 77,500 | 77,700 | -100 | -0.1% | 65 |
2011/07/25 | 77,900 | 78,500 | 77,800 | 77,800 | -200 | -0.3% | 54 |
2011/07/22 | 79,600 | 79,600 | 77,800 | 78,000 | -1,600 | -2% | 114 |
2011/07/21 | 78,900 | 79,700 | 78,200 | 79,600 | +1,800 | +2.3% | 139 |
2011/07/20 | 78,000 | 79,100 | 77,800 | 77,800 | -200 | -0.3% | 110 |
2011/07/19 | 79,100 | 79,100 | 77,700 | 78,000 | -1,300 | -1.6% | 95 |
2011/07/15 | 78,600 | 79,300 | 78,100 | 79,300 | +700 | +0.9% | 118 |
2011/07/14 | 80,900 | 80,900 | 78,600 | 78,600 | -2,400 | -3% | 111 |
2011/07/13 | 79,900 | 81,000 | 79,500 | 81,000 | -100 | -0.1% | 119 |
2011/07/12 | 79,900 | 81,100 | 79,500 | 81,100 | +300 | +0.4% | 111 |
2011/07/11 | 81,300 | 81,300 | 80,600 | 80,800 | +200 | +0.2% | 106 |
2011/07/08 | 80,500 | 81,000 | 80,100 | 80,600 | -200 | -0.2% | 80 |
2011/07/07 | 79,300 | 80,800 | 79,200 | 80,800 | +1,100 | +1.4% | 106 |
2011/07/06 | 81,300 | 81,300 | 78,700 | 79,700 | -600 | -0.7% | 81 |
2011/07/05 | 82,000 | 82,000 | 80,300 | 80,300 | -1,700 | -2.1% | 51 |
2011/07/04 | 80,700 | 82,500 | 79,300 | 82,000 | +2,800 | +3.5% | 255 |
2011/07/01 | 79,300 | 80,000 | 79,000 | 79,200 | +500 | +0.6% | 66 |
2011/06/30 | 79,900 | 79,900 | 78,700 | 78,700 | -1,200 | -1.5% | 69 |
2011/06/29 | 79,300 | 79,900 | 78,200 | 79,900 | +1,000 | +1.3% | 77 |
2011/06/28 | 78,500 | 79,300 | 78,300 | 78,900 | +1,200 | +1.5% | 45 |
2011/06/27 | 77,700 | 78,600 | 77,600 | 77,700 | -1,400 | -1.8% | 120 |
2011/06/24 | 79,200 | 80,000 | 79,000 | 79,100 | -200 | -0.3% | 79 |
2011/06/23 | 81,000 | 82,500 | 79,100 | 79,300 | +800 | +1% | 215 |
2011/06/22 | 78,400 | 79,800 | 78,400 | 78,500 | -200 | -0.3% | 67 |
2011/06/21 | 79,500 | 79,800 | 78,100 | 78,700 | -1,300 | -1.6% | 69 |
2011/06/20 | 80,000 | 80,100 | 78,900 | 80,000 | -400 | -0.5% | 51 |
2011/06/17 | 80,100 | 81,000 | 79,600 | 80,400 | ±0 | ±0% | 69 |
2011/06/16 | 80,500 | 80,800 | 80,200 | 80,400 | -600 | -0.7% | 54 |
2011/06/15 | 81,500 | 81,500 | 80,300 | 81,000 | -500 | -0.6% | 75 |
2011/06/14 | 83,000 | 84,700 | 80,500 | 81,500 | +2,200 | +2.8% | 431 |
2011/06/13 | 79,000 | 79,700 | 78,500 | 79,300 | +300 | +0.4% | 57 |
2011/06/10 | 78,700 | 79,900 | 78,500 | 79,000 | ±0 | ±0% | 48 |
2011/06/09 | 79,900 | 80,000 | 79,000 | 79,000 | -800 | -1% | 58 |
2011/06/08 | 80,000 | 80,500 | 79,400 | 79,800 | +300 | +0.4% | 61 |
2011/06/07 | 77,000 | 80,000 | 77,000 | 79,500 | +2,500 | +3.2% | 109 |
2011/06/06 | 76,500 | 78,100 | 76,500 | 77,000 | -2,200 | -2.8% | 156 |
2011/06/03 | 79,400 | 80,100 | 78,500 | 79,200 | -200 | -0.3% | 80 |
2011/06/02 | 80,500 | 80,500 | 79,000 | 79,400 | -2,100 | -2.6% | 87 |
2011/06/01 | 81,500 | 81,500 | 80,300 | 81,500 | +500 | +0.6% | 91 |
3351~
3400
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アンジェス | 7,000円 | +110.0% | - | 0.00% | - | 11.38倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
ヘリオス | 27,300円 | +150.0% | - | 0.00% | - | 13.43倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ミズホメディ | 148,000円 | +1.2% | -13.9% | 5.74% | 8.73倍 | 1.62倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
扶桑薬 | 232,600円 | +8.3% | +98.1% | 3.53% | 7.64倍 | 0.52倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ステムリム | 32,200円 | - | - | 0.00% | - | 2.97倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム